Patents by Inventor Jian Chai
Jian Chai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240125320Abstract: The present invention relates to a high-power five-cylinder drilling pump set, a solid control system and a drilling rig, which belongs to a technical field of oil drilling equipment. The high-power five-cylinder drilling pump set includes: a base, a drilling pump arranged on the base, and a lubricating system arranged on the base, wherein the drilling pump comprises a transmission assembly, a power end assembly and a hydraulic end assembly; the lubricating system comprises a power end lubricating system for lubricating and cooling the transmission assembly as well as the power end assembly, and a hydraulic end lubricating system for lubricating and cooling the hydraulic end assembly. According to the present invention, the high-power five-cylinder drilling pump set has a modular entire structure. In terms of the spatial layout, the present invention can effectively reduce the excessive size of conventional drilling pump or drilling pump structure.Type: ApplicationFiled: January 25, 2022Publication date: April 18, 2024Inventors: Fangfang Zhang, Jian Cheng, Junqing Chai, Mingpeng Tang, Hui Zeng
-
Publication number: 20240112401Abstract: A system and method are described for generating 3D garments from two-dimensional (2D) scribble images drawn by users. The system includes a conditional 2D generator, a conditional 3D generator, and two intermediate media including dimension-coupling color-density pairs and flat point clouds that bridge the gap between dimensions. Given a scribble image, the 2D generator synthesizes dimension-coupling color-density pairs including the RGB projection and density map from the front and rear views of the scribble image. A density-aware sampling algorithm converts the 2D dimension-coupling color-density pairs into a 3D flat point cloud representation, where the depth information is ignored. The 3D generator predicts the depth information from the flat point cloud. Dynamic variations per garment due to deformations resulting from a wearer's pose as well as irregular wrinkles and folds may be bypassed by taking advantage of 2D generative models to bridge the dimension gap in a non-parametric way.Type: ApplicationFiled: September 30, 2022Publication date: April 4, 2024Inventors: Panagiotis Achlioptas, Menglei Chai, Hsin-Ying Lee, Kyle Olszewski, Jian Ren, Sergey Tulyakov
-
Patent number: 10196360Abstract: Provided are crystal forms I, II, and III of bedaquiline fumarate, and preparation methods thereof. The crystal forms have high purity, excellent physicochemical properties, and good stability. The preparation methods can effectively improve the quality of products, and are applicable to preparation and mass production of medicines.Type: GrantFiled: October 20, 2015Date of Patent: February 5, 2019Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Jinyi Xu, Liang Zhang, Xiangyang Zhang, Xinzeng Wang, Jian Chai, Hongying Luo, Zhiqing Yang
-
Publication number: 20180346506Abstract: The present invention relates to a method for preparing Sofosbuvir crystal form-6. The method is simple in operation, stable in process condition, good in reproducibility, high in yield rate and high in purity, viscous gel-type products are not formed during the process, the problem of blocking of a discharge port is solved, and the method is suitable for mass industrial production and has high economic value.Type: ApplicationFiled: November 11, 2015Publication date: December 6, 2018Applicant: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.Inventors: Yanghui GUO, Shiguo ZHAO, Yue ZHANG, Liang ZHANG, Zhiqing YANG, Jian CHAI
-
Patent number: 10081599Abstract: The present invention relates to a preparation method of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-formamide capable of enabling 4-chlorine-N-methylpyridine-2-formamide to react with 4-amino-3-fluorophenol in the presence of an inorganic base. The present invention employs the inorganic base to replace potassium t-butoxide in the prior art, thus effectively solving the problem of a potential safety hazard of the potassium t-butoxide in industrial production. In addition, after the reaction is completed, the present invention employs a crystallization method for separation to obtain a reaction product; thus compared with the methods of extraction, concentration and column isolation and purification employed in the prior art, the present invention has a simpler operation and a lower cost, results in less environment pollution and a higher yield, and is very suitable for industrial production.Type: GrantFiled: November 9, 2015Date of Patent: September 25, 2018Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Guan Wang, Xufeng Yu, Guo Wei, Jian Chai, Zhiqing Yang
-
Publication number: 20180265473Abstract: Provided are crystal forms I, II, and III of bedaquiline fumarate, and preparation methods thereof. The crystal forms have high purity, excellent physicochemical properties, and good stability. The preparation methods can effectively improve the quality of products, and are applicable to preparation and mass production of medicines.Type: ApplicationFiled: October 20, 2015Publication date: September 20, 2018Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Jinyi Xu, Liang Zhang, Xiangyang Zhang, Xinzeng Wang, Jian Chai, Hongying Luo, Zhiqing Yang
-
Patent number: 10053483Abstract: Provided in the present invention are novel key intermediates of selamectin and the preparation method thereof. Also provided is a new synthesis process, using doramectin as a starting material, and obtaining selamectin via hydrogenation, oxidation, oximation and desugaring. The new process of the present invention has few steps, and is simple to operate, high in yield, low in cost and causes little pollution, and is more suitable for large scale industrial production.Type: GrantFiled: April 2, 2013Date of Patent: August 21, 2018Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Mingxing Yin, Jianchao Wu, Jian Chai
-
Publication number: 20170334856Abstract: The present invention relates to a preparation method of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-formamide capable of enabling 4-chlorine-N-methylpyridine-2-formamide to react with 4-amino-3-fluorophenol in the presence of an inorganic base. The present invention employs the inorganic base to replace potassium t-butoxide in the prior art, thus effectively solving the problem of a potential safety hazard of the potassium t-butoxide in industrial production. In addition, after the reaction is completed, the present invention employs a crystallization method for separation to obtain a reaction product; thus compared with the methods of extraction, concentration and column isolation and purification employed in the prior art, the present invention has a simpler operation and a lower cost, results in less environment pollution and a higher yield, and is very suitable for industrial production.Type: ApplicationFiled: November 9, 2015Publication date: November 23, 2017Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Guan Wang, Xufeng Yu, Guo Wei, Jian Chai, Zhiqing Yang
-
Patent number: 9718802Abstract: The present invention relates to novel crystal forms M and N of dabigatran etexilate mesylate and preparation method and uses thereof, wherein the X-Ray powder diffractogram of the crystal form M has characteristic peaks at the following 2? diffraction angles: 5.7±0.2°, 6.2±0.2°, 11.2±0.2°, 12.4±0.2°, 18.2±0.2°, 21.4±0.2°, 21.8±0.2° and 23.6±0.2°; and the X-Ray powder diffractogram of the crystal form N has characteristic peaks at the following 2? diffraction angles: 6.0±0.2°, 11.8±0.2°, 18.2±0.2°, 21.6±0.2°, 24.4±0.2°, 27.7±0.2° and 29.7±0.2°. The crystal forms of the present invention have excellent properties in the aspects of leaching time, biological release, chemical stability and processing adaptability.Type: GrantFiled: March 4, 2015Date of Patent: August 1, 2017Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Liang Zhang, Chuan Liu, Jinyi Xu, Zhaozhao Zhang, Zhi Chen, Jian Chai, Zhiqing Yang, Hairong Luo, Xiangyang Zhang
-
Patent number: 9676736Abstract: A molecule with neural activities, especially 4-substituent-2-hydroxymorpholin-3-one, as a new intermediate of neurokinin-1 receptor antagonist aprepitant, and preparation method thereof.Type: GrantFiled: April 15, 2013Date of Patent: June 13, 2017Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Fuli Zhang, Chonghao Liu, Pengcheng Qiu, Jian Chai, Qingfeng Cai
-
Publication number: 20170073327Abstract: The present invention relates to novel crystal forms M and N of dabigatran etexilate mesylate and preparation method and uses thereof, wherein the X-Ray powder diffractogram of the crystal form M has characteristic peaks at the following 2? diffraction angles: 5.7±0.2°, 6.2±0.2°, 11.2±0.2°, 12.4±0.2°, 18.2±0.2°, 21.4±0.2°, 21.8±0.2° and 23.6±0.2°; and the X-Ray powder diffractogram of the crystal form N has characteristic peaks at the following 20 diffraction angles: 6.0±0.2°, 11.8±0.2°, 18.2±0.2°, 21.6±0.2°, 24.4±0.2°, 27.7±0.2° and 29.7±0.2°. The crystal forms of the present invention have excellent properties in the aspects of leaching time, biological release, chemical stability and processing adaptability.Type: ApplicationFiled: March 4, 2015Publication date: March 16, 2017Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Liang Zhang, Chuan Liu, Jinyi Xu, Zhaozhao Zhang, Zhi Chen, Jian Chai, Zhiqing Yang, Hairong Luo, Xiangyang Zhang
-
Patent number: 9434702Abstract: Disclosed is a new method for preparing a methyl substitute of a linezolid intermediate, (S)-2-(3-(3-fluoro-4-morpholinophenyl)-2-oxo-5-oxazoline) (I), wherein the intermediate (I) is obtained by the cyclization of 3-fluoro-4-morpholinophenyl isocyanate (II) and epoxy compound (III). This process has a short process route, low cost, easy operation, and high yield, so is suitable for a large-scale industrial production.Type: GrantFiled: February 8, 2013Date of Patent: September 6, 2016Assignees: Zhejiang Hisun Pharamceutical Co., Ltd., Shanghai Institute of Pharmaceutical IndustryInventors: Fuli Zhang, Chunbo Yang, Bin Liang, Pengcheng Qiu, Hairong Luo, Jiang Li, Jian Chai, Qingfeng Cai
-
Patent number: 9221798Abstract: Provided are derivatives substituted by urea associated with 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine-2-amino of formula (I), wherein these compounds may selectively regulate or inhibit an information transmission process controlled by natural or variant tyrosine kinase. Also provided are preparation methods and uses of the compounds.Type: GrantFiled: September 5, 2011Date of Patent: December 29, 2015Assignee: Zhejian Hisun Pharmaceutical Co., Ltd.Inventors: Yili Ding, Xuan Yang, Qingyan Yan, Hua Bai, Lifeng Cai, Kenneth Smith, Jian Chai
-
Publication number: 20150329581Abstract: Provided in the present invention are novel key intermediates of selamectin and the preparation method thereof. Also provided is a new synthesis process, using doramectin as a starting material, and obtaining selamectin via hydrogenation, oxidation, oximation and desugaring. The new process of the present invention has few steps, and is simple to operate, high in yield, low in cost and causes little pollution, and is more suitable for large scale industrial production.Type: ApplicationFiled: April 2, 2013Publication date: November 19, 2015Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Mingxing Yin, Jianchao Wu, Jian Chai
-
Publication number: 20150284419Abstract: Disclosed is a process for chemically synthesizing a pharmaceutical intermediate, in particular to a novel intermediate and novel process for synthesizing an anticoagulant drug fondaparinux sodium intermediate—full protection heparin pentasaccharide. The process has a high reaction efficiency and a simple reaction operation, and enables the reaction intermediate to be easily purified, thus being suitable for the industrialized production of the full protection heparin pentasaccharide.Type: ApplicationFiled: May 25, 2012Publication date: October 8, 2015Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.Inventors: Yili Ding, Yanghui Guo, Hua Bai, Yingqiu Wu, Xuan Yang, Qingyan Yan, Jian Chai
-
Publication number: 20150087828Abstract: A molecule with neural activities, especially 4-substituent-2-hydroxymorpholin-3-one, as a new intermediate of neurokinin-1 receptor antagonist aprepitant, and preparation method thereof.Type: ApplicationFiled: April 15, 2013Publication date: March 26, 2015Applicants: Zhejiang Hisun Pharmaceutical Co., Ltd., Shanghai Institute of Pharmaceutical IndustryInventors: Fuli Zhang, Chonghao Liu, Pengcheng Qiu, Jian Chai, Qingfeng Cai
-
Publication number: 20150011757Abstract: Disclosed is a new method for preparing a methyl substitute of a linezolid intermediate, (S)-2-(3-(3-fluoro-4-morpholinophenyl)-2-oxo-5-oxazoline) (I), wherein the intermediate (I) is obtained by the cyclization of 3-fluoro-4-morpholinophenyl isocyanate (II) and epoxy compound (III). This process has a short process route, low cost, easy operation, and high yield, so is suitable for a large-scale industrial production.Type: ApplicationFiled: February 8, 2013Publication date: January 8, 2015Applicants: Zhejiang Hisun Pharmaceutical Co., Ltd., Shanghai Institute of Pharmaceutical IndustryInventors: Fuli Zhang, Chunbo Yang, Bin Liang, Pengcheng Qiu, Hairong Luo, Jiang Li, Jian Chai, Qingfeng Cai
-
Publication number: 20140378488Abstract: Provided are derivatives substituted by urea associated with 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine-2-amino of formula (I), wherein these compounds may selectively regulate or inhibit an information transmission process controlled by natural or variant tyrosine kinase. Also provided are preparation methods and uses of the compounds.Type: ApplicationFiled: September 5, 2011Publication date: December 25, 2014Applicant: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.Inventors: Yili Ding, Xuan Yang, Qingyan Yan, Hua Bai, Lifeng Cai, Kenneth Smith, Jian Chai